Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypersensitivity Reaction
  Free Subscription

Articles published in
Eur Respir J
    April 2024
  1. KRISHNAN JA, Buhl R
    As-needed ICS/formoterol or as-needed SABA in mild asthma?
    Eur Respir J. 2024;63:2302308.
    >> Share

  2. PAPI A, Ferreira DS, Tonia T, Schleich F, et al
    Response from the authors: As-needed ICS/formoterol or as-needed SABA in mild asthma?
    Eur Respir J. 2024;63:2400395.
    >> Share


  3. ERJ Podcast April 2024: Allergic bronchopulmonary aspergillosis.
    Eur Respir J. 2024;63:24E6304.
    >> Share

  4. BLOOM CI
    Reply: Asthma and cardiovascular disease: the strength of triangulation.
    Eur Respir J. 2024;63:2400554.
    >> Share

  5. TATTERSALL MC, Gangnon RE, Jarjour NN
    Asthma and cardiovascular disease: embracing disease heterogeneity is required.
    Eur Respir J. 2024;63:2400469.
    >> Share

  6. STANESCU C, Talarico R, Weichenthal S, Villeneuve PJ, et al
    Early life exposure to pollens and increased risks of childhood asthma: a prospective cohort study in Ontario children.
    Eur Respir J. 2024;63:2301568.
    >> Share

  7. VARRICCHI G, Brightling CE, Grainge C, Lambrecht BN, et al
    Airway remodelling in asthma and the epithelium: on the edge of a new era.
    Eur Respir J. 2024;63:2301619.
    >> Share

    March 2024
  8. LUO RG, Wu YF, Lu HW, Weng D, et al
    Th2-skewed peripheral T helper cells drives B cells in allergic bronchopulmonary aspergillosis.
    Eur Respir J. 2024 Mar 21:2400386. doi: 10.1183/13993003.00386-2024.
    >> Share

  9. RUSSELL RJ, Boulet LP, Brightling CE, Pavord ID, et al
    The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma.
    Eur Respir J. 2024 Mar 7:2301397. doi: 10.1183/13993003.01397-2023.
    >> Share

    February 2024
  10. AGARWAL R, Singh Sehgal I, Muthu V, Denning DW, et al
    Revised clinical practice guidelines for diagnosing, classifying, and treating allergic bronchopulmonary aspergillosis/mycoses: a Delphi statement from the ISHAM-ABPA working group.
    Eur Respir J. 2024 Feb 29:2400061. doi: 10.1183/13993003.00061-2024.
    >> Share

  11. STANOJEVIC S, Kaminsky DA, Miller MR, Thompson B, et al
    Reply to: ERS/ATS spirometry interpretation standards: a gap in grading severity of airflow obstruction.
    Eur Respir J. 2024;63:2400055.
    >> Share

  12. WANG T, Duan W, Jia X, Huang X, et al
    Associations of combined phenotypic ageing and genetic risk with incidence of chronic respiratory diseases in the UK Biobank: a prospective cohort study.
    Eur Respir J. 2024;63:2301720.
    >> Share

    January 2024
  13. ZHU Z
    Early-life airway microbiome and childhood asthma development.
    Eur Respir J. 2024;63:2302187.
    >> Share

  14. DHOORIA S, Sehgal IS, Agarwal R
    Reply: A suggested classification of disease behaviour and treatment response in sarcoidosis trials.
    Eur Respir J. 2024;63:2302208.
    >> Share

  15. JENY F, Nunes H, Valeyre D
    In sarcoidosis trials, time also matters.
    Eur Respir J. 2024;63:2301629.
    >> Share

  16. HOGMAN M, Bowerman C, Chavez L, Dressel H, et al
    ERS technical standard: Global Lung Function Initiative reference values for exhaled nitric oxide fraction (F (ENO(50)) ).
    Eur Respir J. 2024;63:2300370.
    >> Share


  17. ERJ Podcast January 2024: The microbiome in early life and childhood asthma.
    Eur Respir J. 2024;63:24E6301.
    >> Share

    December 2023
  18. SUNDE RB MD PHD, Thorsen J MD PhD, Kim M MSc PhD, Schoos AM MD PhD, et al
    Bacterial Colonization of the Airway in Neonates and Risk of Asthma and Allergy Until Age 18 Years.
    Eur Respir J. 2023 Dec 14:2300471. doi: 10.1183/13993003.00471-2023.
    >> Share

  19. BEASLEY R, Noble J, Weatherall M
    Clinical remission with biologic therapies in severe asthma: a matter of definition.
    Eur Respir J. 2023;62:2301844.
    >> Share

  20. WECKMANN M, Reddy KD
    Epigenome-wide association studies: the exposures of yesterday form the methylations of tomorrow.
    Eur Respir J. 2023;62:2301552.
    >> Share

    November 2023
  21. VALENCIA-HERNANDEZ CA, Del Greco M F, Sundaram V, Portas L, et al
    Asthma and incident coronary heart disease: an observational and Mendelian randomisation study.
    Eur Respir J. 2023 Nov 9:2301788. doi: 10.1183/13993003.01788-2023.
    >> Share

  22. CIVIDINI S, Sinha I, Donegan S, Maden M, et al
    Best step-up treatments for children with uncontrolled asthma: A systematic review and network meta-analysis of individual participant data.
    Eur Respir J. 2023 Nov 9:2301011. doi: 10.1183/13993003.01011-2023.
    >> Share

  23. MORGAN C, Higbee D
    An attack of asthma is not an attack of the heart: clarifying causal links between asthma and incident coronary heart disease.
    Eur Respir J. 2023;62:2302009.
    >> Share

    October 2023
  24. MCDOWELL PJ, McDowell R, Busby J, Eastwood MC, et al
    Clinical remission in severe asthma with Biologic Therapy: an analysis from the UK Severe Asthma Registry.
    Eur Respir J. 2023 Oct 19:2300819. doi: 10.1183/13993003.00819-2023.
    >> Share

  25. HERRERA-LUIS E, de la Rosa-Baez C, Huntsman S, Eng C, et al
    Novel insights into the whole blood DNA methylome of asthma in ethnically diverse children and youth.
    Eur Respir J. 2023 Oct 6:2300714. doi: 10.1183/13993003.00714-2023.
    >> Share


  26. October Podcast: ERS short guidelines for the use of as-needed ICS/formoterol in mild asthma.
    Eur Respir J. 2023;62:23E6204.
    >> Share

    September 2023
  27. FIOCCHI AG, Phipatanakul W, Zeiger RS, Durrani SR, et al
    Dupilumab leads to better-controlled asthma & quality of life in children: the VOYAGE study.
    Eur Respir J. 2023 Sep 21:2300558. doi: 10.1183/13993003.00558-2023.
    >> Share

  28. PAPI A, Ferreira DS, Agache I, Baraldi E, et al
    European Respiratory Society Short Guidelines for the use of as-needed ICS/formoterol in mild Asthma.
    Eur Respir J. 2023 Sep 7:2300047. doi: 10.1183/13993003.00047-2023.
    >> Share

  29. DHOORIA S, Sehgal IS, Agarwal R, Muthu V, et al
    High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial).
    Eur Respir J. 2023;62:2300198.
    >> Share

    August 2023
  30. VON BULOW A, Hansen S, Sandin P, Ernstsson O, et al
    Severe asthma trajectories in adults: findings from the NORDSTAR cohort.
    Eur Respir J. 2023 Aug 24:2202474. doi: 10.1183/13993003.02474-2022.
    >> Share

  31. POWELL WT, Reeves SR
    From small to big, using microRNA profiling to investigate infant origins of childhood asthma.
    Eur Respir J. 2023;62:2301052.
    >> Share

  32. OSADNIK CR, Brighton LJ, Burtin C, Cesari M, et al
    European Respiratory Society statement on frailty in adults with chronic lung disease.
    Eur Respir J. 2023;62:2300442.
    >> Share

    July 2023
  33. NANZER AM, Taylor V, Hearn AP, Kavanagh JE, et al
    The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma.
    Eur Respir J. 2023 Jul 20:2300245. doi: 10.1183/13993003.00245-2023.
    >> Share

  34. CAZZOLA M, Page CP, Matera MG, Rogliani P, et al
    Revisiting Asthma Pharmacotherapy: Where Do We Stand and Where Do We Want to Go?
    Eur Respir J. 2023 Jul 20:2300700. doi: 10.1183/13993003.00700-2023.
    >> Share

    June 2023
  35. ZHU Z, Freishtat RJ, Harmon B, Hahn A, et al
    Nasal airway microRNA profiling of infants with severe bronchiolitis and risk of childhood asthma: A multicenter prospective study.
    Eur Respir J. 2023 Jun 15:2300502. doi: 10.1183/13993003.00502-2023.
    >> Share

  36. DUIJTS L
    Prematurity-related chronic respiratory disease across the life course.
    Eur Respir J. 2023;61:2300662.
    >> Share

  37. VAN DER VEER T, de Koning Gans JM, Braunstahl GJ, Pieters A, et al
    The effect of beclomethasone-formoterol versus placebo on chronic cough in patients with non-CF bronchiectasis: the FORZA randomised-controlled trial.
    Eur Respir J. 2023 Jun 1:2300186. doi: 10.1183/13993003.00186-2023.
    >> Share

    April 2023
  38. EIWEGGER T, Bendien SA
    Defining the questions to be asked in severe asthma trials: data from the COMSA working group.
    Eur Respir J. 2023;61:2202058.
    >> Share

    March 2023
  39. PULAKKA A, Risnes K, Metsala J, Alenius S, et al
    Preterm birth and asthma and COPD in adulthood: a nationwide register study from two Nordic countries.
    Eur Respir J. 2023 Mar 29:2201763. doi: 10.1183/13993003.01763-2022.
    >> Share

  40. MAHMOUD O, Granell R, Peralta GP, Garcia-Aymerich J, et al
    Early-life and health behaviour influences on lung function in early adulthood.
    Eur Respir J. 2023;61:2001316.
    >> Share

  41. CHARRIOT J, Ahmed E, Bourdin A
    Local targeting of TSLP: feat or defeat.
    Eur Respir J. 2023;61:2202389.
    >> Share

  42. SCHNEIDER S, Poglitsch K, Morgenstern C, Quint T, et al
    Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
    Eur Respir J. 2023;61:2201335.
    >> Share

  43. BOULET LP, Boulay ME, Cote A, FitzGerald JM, et al
    Airway inflammation and hyperresponsiveness in subjects with respiratory symptoms and normal spirometry.
    Eur Respir J. 2023;61:2201194.
    >> Share

  44. NOBLE PB, Donovan GM
    If your patient with asthma wheezes when sitting or lying quietly, lung function testing may reveal small airway disease.
    Eur Respir J. 2023;61:2202307.
    >> Share

  45. CORREN J, Brightling CE, Boulet LP, Porsbjerg C, et al
    Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond.
    Eur Respir J. 2023;61:2202202.
    >> Share

    February 2023
  46. GAUVREAU GM, Hohlfeld JM, FitzGerald MJ, Boulet LP, et al
    Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
    Eur Respir J. 2023 Feb 23:2201193. doi: 10.1183/13993003.01193-2022.
    >> Share

  47. ABDO M, Kirsten AM, von Mutius E, Kopp M, et al
    Minimal Clinically Important Difference for Impulse Oscillometry in Adults with Asthma.
    Eur Respir J. 2023 Feb 9:2201793. doi: 10.1183/13993003.01793-2022.
    >> Share

  48. SAVOURE M, Bousquet J, Leynaert B, Renuy A, et al
    Rhinitis phenotypes and multimorbidities in the general population: the CONSTANCES cohort.
    Eur Respir J. 2023;61:2200943.
    >> Share

    January 2023
  49. POLLOCK J, Chalmers JD
    Aspergillus sensitisation: an underappreciated treatable trait in airway disease.
    Eur Respir J. 2023;61:2202042.
    >> Share

  50. FAWCETT KA
    Seeing the trees for the wood: reducing heterogeneity in genomic studies of asthma.
    Eur Respir J. 2023;61:2201931.
    >> Share

    December 2022
  51. DAVIES D, Hyland ME, Lanario JW, Jones RC, et al
    Moving towards patient-centred outcomes: the Severe Asthma Questionnaire.
    Eur Respir J. 2022 Dec 30:2202305. doi: 10.1183/13993003.02305-2022.
    >> Share

  52. FAROOQI MM, Hambly N, Ryerson CJ, Kolb M, et al
    Reply: risk factors for disease progression in fibrotic hypersensitivity pneumonitis.
    Eur Respir J. 2022 Dec 22:2202261. doi: 10.1183/13993003.02261-2022.
    >> Share

  53. FUJIMOTO H, Yasuma T, D'Alessandro-Gabazza CN, Gabazza EC, et al
    Risk Factors for Disease Progression in Fibrotic Hypersensitivity Pneumonitis.
    Eur Respir J. 2022 Dec 22:2201706. doi: 10.1183/13993003.01706-2022.
    >> Share

  54. RATTU A, Khaleva E, Brightling C, Dahlen SE, et al
    Identifying and appraising outcome measures for severe asthma: a systematic review.
    Eur Respir J. 2022 Dec 22:2201231. doi: 10.1183/13993003.01231-2022.
    >> Share

  55. KOCKS J, van der Molen T, Voorham J, Baldi S, et al
    Development of a tool to detect small airways dysfunction in asthma clinical practice.
    Eur Respir J. 2022 Dec 14:2200558. doi: 10.1183/13993003.00558-2022.
    >> Share

  56. HAHN DL, Webley W
    U-BIOPRED/BIOAIR proteins: inflammation or infection?
    Eur Respir J. 2022;60:2200571.
    >> Share

  57. SPARREMAN MIKUS M, Kolmert J, Andersson LI, Dahlen SE, et al
    Reply: U-BIOPRED/BIOAIR proteins: inflammation or infection?
    Eur Respir J. 2022;60:2201795.
    >> Share

  58. MENZIES-GOW A, Gurnell M, Heaney LG, Corren J, et al
    Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study.
    Eur Respir J. 2022;60:2103226.
    >> Share

    November 2022
  59. CHERIAN M, Magner KMA, Whitmore GA, Vandemheen KL, et al
    Patient and physician factors associated with symptomatic undiagnosed asthma or COPD.
    Eur Respir J. 2022 Nov 3. pii: 13993003.01721-2022.
    >> Share

  60. BUSSE WW
    Improving systemic corticosteroid stewardship in asthma.
    Eur Respir J. 2022;60.
    >> Share

  61. PARK JS, Cho YJ, Yun JY, Lee HJ, et al
    Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Eur Respir J. 2022;60.
    >> Share

  62. ROBERTS G
    Is it time to consider allergen immunotherapy earlier in the management of allergic asthma?
    Eur Respir J. 2022;60.
    >> Share

  63. PETSKY H
    Randomised controlled trials utilising F ENO to manage asthma: is it time to acknowledge that "one size does not fit all"?
    Eur Respir J. 2022;60.
    >> Share

  64. GODET C, Cadranel J, Frat JP, Ragot S, et al
    Reply to: Nebulised liposomal amphotericin-B: a promising strategy for preventing ABPA relapse.
    Eur Respir J. 2022;60:2201678.
    >> Share

  65. LIU Y, Lu HW, Xu JF
    Nebulised liposomal amphotericin-B: a promising strategy for preventing ABPA relapse.
    Eur Respir J. 2022;60:2201332.
    >> Share

    October 2022
  66. KHALEVA E, Rattu A, Brightling C, Bush A, et al
    Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).
    Eur Respir J. 2022 Oct 13. pii: 13993003.00606-2022.
    >> Share

  67. POLVERINO F, Marin JM
    The lower respiratory tract: the hot spot for chronic fixed airflow limitation.
    Eur Respir J. 2022;60.
    >> Share

  68. HAMBLY N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, et al
    Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
    Eur Respir J. 2022;60.
    >> Share

  69. AGARWAL R, Sehgal IS, Muthu V, Dhooria S, et al
    Estimating the minimal important difference in FEV1 for patients with allergic bronchopulmonary aspergillosis.
    Eur Respir J. 2022;60.
    >> Share

    September 2022
  70. PERSSON C
    Creola bodies and pathogenesis of childhood asthma.
    Eur Respir J. 2022 Sep 30. pii: 13993003.01204-2022.
    >> Share

  71. LIU J, Bowatte G, Pham J, Perret JL, et al
    Pre-pubertal smoke exposure of fathers and increased risk of offspring asthma: a possible transgenerational effect.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00257-2022.
    >> Share

  72. COLEMAN C, Khaleva E, Rattu A, Frankemolle B, et al
    Narrative Review to capture patients' perceptions and opinions about non-response and response to biological therapy for severe asthma.
    Eur Respir J. 2022 Sep 14. pii: 13993003.00837-2022.
    >> Share

  73. SORIANO JB
    Planetary respiratory health for asthma, rhinoconjunctivitis and eczema.
    Eur Respir J. 2022;60.
    >> Share

  74. CHAN JSK, Murray RB, Price D
    Oral corticosteroids in asthma and beyond: moving forward.
    Eur Respir J. 2022;60.
    >> Share

  75. PAVORD ID
    Case-finding and diagnosis of obstructive airway diseases: the Dragons' Den experience.
    Eur Respir J. 2022;60.
    >> Share

  76. PERREM L, Subbarao P
    Moving the dial on identifying endotypes of asthma from early life.
    Eur Respir J. 2022;60.
    >> Share

    August 2022
  77. CHAN R, Lipworth B
    Interactions between spirometry and oscillometry in patients with moderate to severe asthma.
    Eur Respir J. 2022 Aug 18. pii: 13993003.00543-2022.
    >> Share

  78. LEE S, Prokopenko D, Kelly RS, Lutz S, et al
    Zinc finger protein 33B demonstrates sex-interaction with atopy-related markers in childhood asthma.
    Eur Respir J. 2022 Aug 11. pii: 13993003.00479-2022.
    >> Share

  79. TIEW PY, Narayana JK, Li Quek MS, Ang YY, et al
    Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD.
    Eur Respir J. 2022 Aug 4. pii: 13993003.00507-2022.
    >> Share

    July 2022
  80. PERRET JL, Dharmage SC, Bui DS
    Early life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?
    Eur Respir J. 2022 Jul 26. pii: 13993003.01141-2022.
    >> Share

  81. VAN MEEL ER, Duijts L
    Reply to: "Early-life respiratory infections and pre-adult asthma: could there be an interaction and differential misclassification?"
    Eur Respir J. 2022 Jul 26. pii: 13993003.01384-2022.
    >> Share

  82. MCLOUGHLIN RF, Clark VL, Urroz PD, Gibson PG, et al
    Increasing physical activity in severe asthma: a systematic review and meta-analysis.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00546-2022.
    >> Share

  83. WURZEL D, Licciardi PV
    Targeted strategies are needed to prevent childhood asthma.
    Eur Respir J. 2022;60.
    >> Share

  84. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
    Eur Respir J. 2022;60.
    >> Share

  85. COUILLARD S
    The alarmin(g) effect of interleukin-5 blockade on residual eosinophil function is of clinical consequence.
    Eur Respir J. 2022;60.
    >> Share

  86. WARK PAB
    We need to understand why viral infections lead to acute asthma.
    Eur Respir J. 2022;60.
    >> Share

  87. MURPHY VE, Jensen ME, Holliday EG, Giles WB, et al
    Effect of asthma management with exhaled nitric oxide versus usual care on perinatal outcomes.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00298-2022.
    >> Share

  88. SALTER B, Zhao N, Son K, Suray Tan N, et al
    Airway autoantibodies are determinants of asthma severity.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00442-2022.
    >> Share

  89. REDMOND C, Heaney LG, Chaudhuri R, Jackson DJ, et al
    Benefits of specialist severe asthma management: demographic and geographic disparities.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00660-2022.
    >> Share

  90. HOLMES J, McGarvey LP, Birring SS, Fletcher H, et al
    An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma.
    Eur Respir J. 2022 Jul 1. pii: 13993003.03205-2021.
    >> Share

    June 2022
  91. BATEMAN ED, Price DB, Wang HC, Schonffeldt P, et al
    Reply to: Cause or consequence?
    Eur Respir J. 2022;59.
    >> Share

  92. VOLPE FM
    Cause or consequence?
    Eur Respir J. 2022;59.
    >> Share

  93. GODET C, Couturaud F, Marchand-Adam S, Pison C, et al
    Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
    Eur Respir J. 2022;59.
    >> Share

    May 2022
  94. WOEHLK C, Von Bulow A, Ghanizada M, Baastrup Sondergaard M, et al
    Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
    Eur Respir J. 2022 May 26. pii: 13993003.00446-2022.
    >> Share

  95. SUN Y, Zhang M, Ou Z, Meng Y, et al
    Indoor microbiome, microbial and plant metabolites, chemical compounds and asthma symptoms in junior high school students: a multicentre association study in Malaysia.
    Eur Respir J. 2022 May 26. pii: 13993003.00260-2022.
    >> Share

  96. HUMBERT M, Bourdin A, Taille C, Kamar D, et al
    Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics.
    Eur Respir J. 2022 May 26. pii: 13993003.03130-2021.
    >> Share

  97. HABENER A, Grychtol R, Gaedcke S, DeLuca D, et al
    IgA(+) memory B cells are significantly increased in patients with asthma and small airways dysfunction.
    Eur Respir J. 2022 May 20. pii: 13993003.02130-2021.
    >> Share

  98. KROES JA, Zielhuis SW, De Jong K, Hashimoto S, et al
    Cumulative Corticosteroid Sparing Effect of Anti-Interleukin-5/5Ra In Eosinophilic Asthma.
    Eur Respir J. 2022 May 20. pii: 13993003.02983-2021.
    >> Share

  99. GAIETTO K, Han YY, Forno E, Bacharier LB, et al
    Violence-related distress and lung function in two longitudinal studies of youth.
    Eur Respir J. 2022;59.
    >> Share

    April 2022
  100. RABE KF, Pavord ID, Castro M, Wechsler ME, et al
    Dupilumab efficacy and safety in patients with asthma and blood eosinophils >/=500 cells.microL(-1).
    Eur Respir J. 2022 Apr 29. pii: 13993003.02577-2021.
    >> Share

  101. VAN MEEL ER, Mensink-Bout SM, den Dekker HT, Ahluwalia TS, et al
    Early-life respiratory tract infections and the risk of school-age lower lung function and asthma: a meta-analysis of 150 000 European children.
    Eur Respir J. 2022 Apr 29. pii: 13993003.02395-2021.
    >> Share

  102. MENSINK-BOUT SM, van Meel ER, de Jongste JC, Annesi-Maesano I, et al
    Maternal diet in pregnancy and child's respiratory outcomes: an individual participant data meta-analysis of 18 000 children.
    Eur Respir J. 2022;59.
    >> Share

  103. SINGH D, Beier J, Astbury C, Belvisi MG, et al
    The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
    Eur Respir J. 2022;59.
    >> Share

    March 2022
  104. THOMAS D, McDonald VM, Pavord ID, Gibson PG, et al
    Asthma remission- what is it and how can it be achieved?
    Eur Respir J. 2022 Mar 31. pii: 13993003.02583-2021.
    >> Share

  105. HUYNH C, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Derivation and Validation of the UCAP-Q Case-finding Questionnaire to Detect Undiagnosed Asthma and COPD.
    Eur Respir J. 2022 Mar 24. pii: 13993003.03243-2021.
    >> Share

  106. HAN YY, Yan Q, Chen W, Celedon JC, et al
    Child maltreatment, anxiety and depression, and asthma among British adults in the UK Biobank.
    Eur Respir J. 2022 Mar 17. pii: 13993003.03160-2021.
    >> Share

  107. BAL C, Idzko M, Skrgat S, Koch A, et al
    FeNO is associated with disease burden in the German Asthma Net severe asthma cohort.
    Eur Respir J. 2022 Mar 10. pii: 13993003.01233-2021.
    >> Share

  108. PETNAK T, Thongprayoon C, Baqir M, Ryu JH, et al
    Antigen Identification and Avoidance on Outcomes in Fibrotic Hypersensitivity Pneumonitis.
    Eur Respir J. 2022 Mar 2. pii: 13993003.01336-2021.
    >> Share

  109. KLEIN DK, Silberbrandt A, Frossing L, Hvidtfeldt M, et al
    Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
    Eur Respir J. 2022 Mar 2. pii: 13993003.02446-2021.
    >> Share

  110. VONK JM, Roukema J
    Air pollution susceptibility in children with asthma and obesity: tidal volume as key player?
    Eur Respir J. 2022;59.
    >> Share

  111. THAMRIN C, Robinson PD, Farah CS, King GG, et al
    Technical standards for respiratory oscillometry and bronchodilator response cut-offs.
    Eur Respir J. 2022;59.
    >> Share

  112. DAGHER R, Kumar V, Copenhaver AM, Gallagher S, et al
    Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity.
    Eur Respir J. 2022;59.
    >> Share

    February 2022
  113. ALI GB, Lowe AJ, Perret JL, Walters EH, et al
    Impact of lifetime body mass index trajectories on the incidence and persistence of adult asthma.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02286-2021.
    >> Share

  114. MORTIMER K, Reddel HK, Pitrez PM, Bateman ED, et al
    Asthma management in low- and middle-income countries: case for change.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03179-2021.
    >> Share

  115. MORTIMER K, Lesosky M, Garcia-Marcos L, Innes Asher M, et al
    The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02865-2021.
    >> Share

  116. MOSLEMI A, Kontogianni K, Brock J, Wood S, et al
    Differentiating COPD and Asthma using Quantitative CT Imaging and Machine Learning.
    Eur Respir J. 2022 Feb 24. pii: 13993003.03078-2021.
    >> Share

  117. MAISON N, Omony J, Illi S, Thiele D, et al
    T-high asthma phenotypes across life span.
    Eur Respir J. 2022 Feb 24. pii: 13993003.02288-2021.
    >> Share

  118. TAYTARD J, Koskas M, Beydon N
    Spirometry forced expiratory time is driven by airflow limitation in asthmatic children.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02620-2021.
    >> Share

  119. SKOV IR, Madsen H, Henriksen DP, Andersen JH, et al
    Low dose oral corticosteroids in asthma associates with increased morbidity and mortality.
    Eur Respir J. 2022 Feb 10. pii: 13993003.03054-2021.
    >> Share

  120. GARCIA-MARCOS L, Innes Asher M, Pearce N, Ellwood E, et al
    The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.
    Eur Respir J. 2022 Feb 10. pii: 13993003.02866-2021.
    >> Share

  121. MARCON A, Locatelli F, Accordini S
    The coexistence of asthma and COPD: some considerations about prevalence and lung function decline.
    Eur Respir J. 2022 Feb 3. pii: 13993003.00096-2022.
    >> Share

  122. SEYS SF, Long MB
    The quest for biomarkers in asthma: challenging the T2 versus non-T2 paradigm.
    Eur Respir J. 2022;59.
    >> Share

    January 2022
  123. GAUVREAU GM, Davis BE, Scadding G, Boulet LP, et al
    Allergen Provocation Tests in Respiratory Research: Building on 50 Years of Experience.
    Eur Respir J. 2022 Jan 27. pii: 13993003.02782-2021.
    >> Share

  124. RICCARDI D, Ward JP, Yarova PL, Janssen LJ, et al
    Topical therapy with negative allosteric modulators of the calcium-sensing receptor (calcilytics) for the management of asthma: the beginning of a new era?
    Eur Respir J. 2022 Jan 20. pii: 13993003.02103-2021.
    >> Share

  125. AL-SHAIKHLY T, Murphy RC, Parker A, Lai Y, et al
    Location of eosinophils in the airway wall is critical for specific features of airway hyperresponsiveness and T2 inflammation in asthma.
    Eur Respir J. 2022 Jan 13. pii: 13993003.01865-2021.
    >> Share

  126. RAMIS J, Middlewick R, Pappalardo F, Cairns JT, et al
    Lysyl oxidase-like 2 is increased in asthma and contributes to asthmatic airway remodelling.
    Eur Respir J. 2022 Jan 7. pii: 13993003.04361-2020.
    >> Share

  127. PEROTIN JM, Wheway G, Tariq K, Azim A, et al
    Vulnerability to acid reflux of the airway epithelium in severe asthma.
    Eur Respir J. 2022 Jan 7. pii: 13993003.01634-2021.
    >> Share

  128. BENSON VS, Hartl S, Barnes N, Galwey N, et al
    Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis.
    Eur Respir J. 2022;59.
    >> Share

    December 2021
  129. RAITA Y, Perez-Losada M, Freishtat RJ, Hahn A, et al
    Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02293-2021.
    >> Share

  130. PORSBJERG C, Nieto-Fontarigo JJ, Cerps S, Ramu S, et al
    Phenotype and severity of asthma determines bronchial epithelial immune responses to a viral mimic.
    Eur Respir J. 2021 Dec 16. pii: 13993003.02333-2021.
    >> Share

  131. AGARWAL R, Muthu V
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02989-2021.
    >> Share

  132. HAVETTE A, Regard L, Roche N, Burgel PR, et al
    Prednisolone plus itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma: is the benefit worth the risk?
    Eur Respir J. 2021 Dec 9. pii: 13993003.02924-2021.
    >> Share

  133. KRUIZINGA MD, Essers E, Stuurman FE, Yavuz Y, et al
    Clinical validation of digital biomarkers for pediatric patients with asthma and cystic fibrosis - Potential for clinical trials and clinical care.
    Eur Respir J. 2021 Dec 9. pii: 13993003.00208-2021.
    >> Share

  134. GURDENIZ G, Ernst M, Rago D, Kim M, et al
    Neonatal metabolome of cesarean section and risk of childhood asthma.
    Eur Respir J. 2021 Dec 9. pii: 13993003.02406-2021.
    >> Share

  135. RYAN D, Sabroe I
    Identifying and addressing health inequalities in asthma care.
    Eur Respir J. 2021;58.
    >> Share

  136. PAPAIOANNOU AI, Photiades A, Gaga M
    Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients.
    Eur Respir J. 2021;58.
    >> Share

  137. PARK S, Lee S, Kim Y, Cho S, et al
    Kidney function and obstructive lung disease: a bidirectional Mendelian randomisation study.
    Eur Respir J. 2021;58.
    >> Share

    November 2021
  138. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
    A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
    Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.
    >> Share

  139. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
    Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
    Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
    >> Share

  140. MIKUS MS, Kolmert J, Andersson LI, Ostling J, et al
    Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.
    Eur Respir J. 2021 Nov 4. pii: 13993003.00142-2021.
    >> Share

  141. OLIVER BG
    Food for thought: why is there more airway smooth muscle in asthma?
    Eur Respir J. 2021;58.
    >> Share

  142. MANNINO DM
    Asthma, COPD and their overlap: coexistence or something more?
    Eur Respir J. 2021;58.
    >> Share

    October 2021
  143. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    >> Share

  144. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    >> Share

  145. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Eur Respir J. 2021 Oct 19. pii: 13993003.02730-2021.
    >> Share

  146. CHAN R, Misirovs R, Lipworth B
    Repeatability of impulse oscillometry in patients with severe asthma.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01679-2021.
    >> Share

  147. SUN Y, Xia PF, Xie J, Mustieles V, et al
    Association of blood trihalomethane concentrations with asthma in U.S. adolescents: nationally representative cross-sectional study.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01440-2021.
    >> Share

  148. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.
    >> Share

    September 2021
  149. MIURA S, Iwamoto H, Omori K, Yamaguchi K, et al
    Accelerated decline in lung function in adults with a history of remitted childhood asthma.
    Eur Respir J. 2021 Sep 29. pii: 13993003.00305-2021.
    >> Share

  150. PANAGOU P, Tzilas V, Bouros D
    "Dynamic (C dyn) lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction" ERJ 2021 58: 2004400.
    Eur Respir J. 2021 Sep 24. pii: 13993003.02361-2021.
    >> Share

  151. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
    Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
    Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
    >> Share

  152. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
    Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
    Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
    >> Share

  153. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma.
    Eur Respir J. 2021 Sep 2. pii: 13993003.00935-2021.
    >> Share

  154. GARCIA-LARSEN V
    Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon?
    Eur Respir J. 2021;58.
    >> Share

  155. RUFFLES T, Lipworth B, Mukhopadhyay S
    Considerations of a real life pragmatic clinical trial in adolescent asthma.
    Eur Respir J. 2021;58.
    >> Share

  156. VAN BOVEN JFM, Dierick BJH, Usmani OS
    When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
    Eur Respir J. 2021;58.
    >> Share

    August 2021
  157. ROFFEL MP, Boudewijn IM, van Nijnatten JLL, Faiz A, et al
    Identification of asthma associated microRNAs in bronchial biopsies.
    Eur Respir J. 2021 Aug 26. pii: 13993003.01294-2021.
    >> Share

  158. WU M, Xie J, Wang Y, Tian Y, et al
    Greenness and eosinophilic asthma: Findings from the UK Biobank.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01597-2021.
    >> Share

  159. SUNJAYA AP, Allida SM, Di Tanna GL, Jenkins CR, et al
    Asthma and Coronavirus Disease 2019 Risk: a systematic review and meta-analysis.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01209-2021.
    >> Share

  160. AFSHAR-MOHAJER N, Wu TD, Shade R, Brigham E, et al
    Obesity, tidal volume, and pulmonary deposition of fine particulate matter in children with asthma.
    Eur Respir J. 2021 Aug 12. pii: 13993003.00209-2021.
    >> Share

    July 2021
  161. BUSSE WW, Paggiaro P, Munoz X, Casale TB, et al
    Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma.
    Eur Respir J. 2021 Jul 29. pii: 13993003.04605-2020.
    >> Share

  162. HAN YY, Forno E, Bacharier LB, Phipatanakul W, et al
    Vitamin D supplementation, lung function, and asthma control in children with asthma and low vitamin D levels.
    Eur Respir J. 2021 Jul 29. pii: 13993003.00989-2021.
    >> Share

  163. CORREN J, Katelaris CH, Castro M, Maspero JF, et al
    Effect of exacerbation history on clinical response to dupilumab in moderate-severe uncontrolled asthma.
    Eur Respir J. 2021 Jul 15. pii: 13993003.04498-2020.
    >> Share

    June 2021
  164. MOORE WC, Kornmann O, Humbert M, Poirier C, et al
    Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
    Eur Respir J. 2021 Jun 25. pii: 13993003.00396-2021.
    >> Share

  165. KRAFT M, Brusselle G, Mark FitzGerald J, Pavord ID, et al
    Patient characteristics, biomarkers, and exacerbation risk in severe, uncontrolled asthma.
    Eur Respir J. 2021 Jun 10. pii: 13993003.00413-2021.
    >> Share

    May 2021
  166. BENLALA I, Dournes G, Girodet PO, Benkert T, et al
    Evaluation of bronchial wall thickness in asthma using magnetic resonance imaging.
    Eur Respir J. 2021 May 28. pii: 13993003.00329-2021.
    >> Share

  167. JENDZJOWSKY N, Laing A, Malig M, Matyas J, et al
    Long-term modulation of airway remodeling in severe asthma following bronchial thermoplasty.
    Eur Respir J. 2021 May 28. pii: 13993003.00622-2021.
    >> Share

  168. SVERRILD A, Hansen S, Hvidtfeldt M, Clausson CM, et al
    The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM).
    Eur Respir J. 2021 May 28. pii: 13993003.01296-2021.
    >> Share

  169. HAKANSSON KEJ, Backer V, Suppli Ulrik C
    Socioeconomic biases in asthma control and specialist referral of possible severe asthma.
    Eur Respir J. 2021 May 13. pii: 13993003.00741-2021.
    >> Share

  170. JOHANSSON H, Wollmer P, Sundstrom J, Janson C, et al
    Bronchodilator response in FOT parameters in middle-aged adults from SCAPIS - normal values and relation to asthma and wheezing.
    Eur Respir J. 2021 May 6. pii: 13993003.00229-2021.
    >> Share

    April 2021
  171. GAILLARD EA, Kuehni CE, Turner S, Goutaki M, et al
    European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.
    Eur Respir J. 2021 Apr 19. pii: 13993003.04173-2020.
    >> Share

  172. MARCON A, Locatelli F, Dharmage SC, Svanes C, et al
    The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04656-2020.
    >> Share

  173. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    >> Share

  174. TALAEI M, Hughes DA, Mahmoud O, Emmett PM, et al
    Dietary intake of vitamin A, lung function, and incident asthma in childhood.
    Eur Respir J. 2021 Apr 1. pii: 13993003.04407-2020.
    >> Share

    March 2021
  175. KNIHTILA HM, Kelly RS, Brustad N, Huang M, et al
    Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze.
    Eur Respir J. 2021 Mar 2. pii: 13993003.02012-2020.
    >> Share

    February 2021
  176. REDDEL HK, Vestbo J, Agusti A, Anderson GP, et al
    Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.
    Eur Respir J. 2021 Feb 25. pii: 13993003.03927-2020.
    >> Share

    January 2021
  177. ROGLIANI P, Ritondo BL, Calzetta L
    Triple therapy in uncontrolled asthma: a network meta-analysis of Phase III studies.
    Eur Respir J. 2021 Jan 28. pii: 13993003.04233-2020.
    >> Share

  178. TALAEI M, Sdona E, Calder PC, Jones LR, et al
    Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype, and incident asthma.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03633-2020.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016